SCHEMBL7210508

SCHEMBL7210508

FC(F)(F)c1cccc(-c2ncccn2)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 1/20 0.53
SCN2A Q99250 2/20 0.51
NPC1 O15118 1/20 0.50
RAB9A P51151 1/20 0.50
KMO O15229 2/20 0.49
NOTUM Q6P988 1/20 0.49
NPY5R Q15761 1/20 0.48
CLK4 Q9HAZ1 2/20 0.47
DYRK1A Q13627 1/20 0.47
SLC6A7 Q99884 1/20 0.47
HRH1 P35367 1/20 0.46
HRH4 Q9H3N8 1/20 0.46
CTSS P25774 2/20 0.46
MAOB P27338 1/20 0.46
CTSK P43235 1/20 0.46
GRIN1 Q05586 1/20 0.46
GRIN2B Q13224 1/20 0.46
PDCD1 Q15116 1/20 0.46
CD274 Q9NZQ7 1/20 0.46
NR1H4 Q96RI1 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28461127 0.85 IDO1 (0.50) IDO1SCN2ANPC1RAB9AKMO
SCHEMBL14338262 0.83 IDO1 (0.56) IDO1SCN2ANPC1RAB9ANOTUM
SCHEMBL40311 0.82 TSHR (0.53) IDO1SCN2ANPC1RAB9ANOTUM
SCHEMBL29206336 0.81 KMO (0.48) IDO1SCN2ANPC1RAB9AKMO
SCHEMBL2666275 0.81 KMO (0.48) IDO1SCN2ANPC1RAB9AKMO
SCHEMBL6232790 0.81 NOS3 (0.50) IDO1SCN2ANPC1RAB9AKMO
SCHEMBL30463196 0.81 IDO1 (0.39) IDO1SCN2ANPC1RAB9AKMO
SCHEMBL29678302 0.80 TSHR (0.58) IDO1SCN2ANOTUMCTSSMAOB
SCHEMBL1263144 0.80 TSHR (0.58) IDO1SCN2ANOTUMCTSSMAOB
SCHEMBL14357355 0.80 KIF11 (0.61) CLK4DYRK1ACTSSCTSK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104884456-B PI3K and/or mTOR inhibitors 山东轩竹医药科技有限公司 2017-08-11 CN disclosed
CN-104884456-A Pi3k and/or mtor inhibitor KBP BIOSCIENCES CO LTD 2015-09-02 CN disclosed
EP-1314732-A2 Substituted pyrimidine compounds and their use AMGEN INC. (US) 2003-05-28 EP disclosed